A detailed history of Fact Capital, LP transactions in Boston Scientific Corp stock. As of the latest transaction made, Fact Capital, LP holds 228,369 shares of BSX stock, worth $19.2 Million. This represents 6.27% of its overall portfolio holdings.

Number of Shares
228,369
Previous 242,119 5.68%
Holding current value
$19.2 Million
Previous $16.6 Billion 6.05%
% of portfolio
6.27%
Previous 6.03%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$67.33 - $77.71 $925,787 - $1.07 Million
-13,750 Reduced 5.68%
228,369 $17.6 Billion
Q4 2023

Feb 14, 2024

SELL
$48.64 - $57.81 $821,043 - $975,832
-16,880 Reduced 6.52%
242,119 $173,000
Q3 2023

Nov 14, 2023

SELL
$50.19 - $54.68 $2.11 Million - $2.29 Million
-41,965 Reduced 13.94%
258,999 $13.7 Billion
Q1 2023

May 15, 2023

SELL
$45.09 - $50.03 $120,255 - $133,430
-2,667 Reduced 0.88%
300,964 $15.1 Billion
Q4 2022

Feb 13, 2023

BUY
$39.56 - $47.22 $12 Million - $14.3 Million
303,631 New
303,631 $14 Billion

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $120B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Fact Capital, LP Portfolio

Follow Fact Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fact Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Fact Capital, LP with notifications on news.